A., Jachimska, B., Komorek, P., Mulheran, P
Presented at: American Diabetes Association Scientific Sessions
However, liraglutide treatment failed to show significant improvement of the UACR and eGFR trajectory in comparison to placebo ( The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study assessed the CV outcome of liraglutide (1.8 mg) in comparison to placebo (Marso et al., 2016b)
In the semaglutide group, 86% achieved at least a 5% weight loss, and 69% lost over 10% of their baseline weight [16]
Some potential benefits of glutathione for liver health include reducing oxidative stress, supporting liver detoxification, protecting liver cells from damage, and promoting overall liver function